COMPARISON OF EFFECTIVENESS AND SAFETY BETWEEN VITAMIN-K ANTAGONIST AND FACTOR XA NON-VITAMIN-K ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION AND RENAL DISEASE

Objective:Atrial fibrillation and renal disease are important co-morbidities in patients with arterial hypertension. There is a strong relationship between renal function and thromboembolic events in patients with non-valvular atrial fibrillation (NVAF).Design and method:Data from German sick funds